BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haggerty, H
Right arrow Articles by Clarke, M P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haggerty, H
Right arrow Articles by Clarke, M P
British Journal of Ophthalmology 2004;88:233-235
© 2004 BMJ Publishing Group Ltd


SCIENTIFIC REPORT

The Newcastle Control Score: a new method of grading the severity of intermittent distance exotropia

H Haggerty1, S Richardson1, S Hrisos2, N P Strong1, M P Clarke1,2

1 Orthoptic Department and Children’s Eye Clinic, Eye Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK
2 School of Neurology, Neurobiology and Psychiatry, Faculty of Medicine, University of Newcastle upon Tyne, UK

Correspondence to:
Correspondence to:
Helen Haggerty
Orthoptic Department, Claremont Wing, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK; helen.haggerty{at}nuth.northy.nhs.uk


ABSTRACT
Aim: To describe the development and application of a novel scoring system for grading the severity of intermittent distance exotropia (IDEX) and its potential application as an intervention criterion for surgical intervention.

Methods: The Newcastle Control Score (NCS) for IDEX was developed by incorporating both subjective (home control) and objective (clinic control) criteria into a scale to grade severity. The score structure described was evaluated for interobserver and test-retest reliability. To determine an optimal score threshold for surgical intervention, 170 cases of IDEX were scored retrospectively. Cure rates for surgical and non-surgical cases were then compared according to preoperative or presenting scores.

Results: Interobserver and test-test reliability were good (r = 0.82 and r = 0.89 respectively). Total cure rate with surgery was 54% and without surgery 18% ({chi}2 = 23.093, df = 1, p<0.001). Significantly fewer patients with NCS >=3 achieved cure without surgery than those with NCS 2 ({chi}2 = 3.362, df = 1, p<0.047).

Conclusions: The NCS is a reliable method for grading the severity of IDEX and aids decisions regarding intervention. Patients with a score of 3 or more are unlikely to attain a cure without surgery.


Keywords: intermittent; exotropia; control; surgery

Abbreviations: BSV, binocular single vision; IDEX, intermittent distance exotropia; NCS, Newcastle Control Score




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
D Buck, M P Clarke, H Haggerty, S Hrisos, C Powell, J Sloper, and N P Strong
Grading the severity of intermittent distance exotropia: the revised Newcastle Control Score
Br. J. Ophthalmol., April 1, 2008; 92(4): 577 - 577.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S R Hatt, H Haggerty, D Buck, W Adams, N P Strong, and M P Clarke
Distance stereoacuity in intermittent exotropia
Br. J. Ophthalmol., February 1, 2007; 91(2): 219 - 221.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
D. Buck, S. R Hatt, H. Haggerty, S. Hrisos, N. P Strong, N. I Steen, and M. P Clarke
The use of the Newcastle Control Score in the management of intermittent exotropia
Br. J. Ophthalmol., February 1, 2007; 91(2): 215 - 218.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.